Edition:
United Kingdom

People: ArQule Inc (ARQL.OQ)

ARQL.OQ on NASDAQ Stock Exchange Global Market

9.24USD
5:16pm BST
Change (% chg)

$0.31 (+3.47%)
Prev Close
$8.93
Open
$8.93
Day's High
$9.32
Day's Low
$8.90
Volume
137,798
Avg. Vol
743,723
52-wk High
$12.21
52-wk Low
$2.23

Loberg, Michael 

Dr. Michael D. Loberg, Ph.D., is an Independent Director of the Company., since January 17, 2007. Dr. Loberg has been a director since January 2007. Previously, he served as Chief Executive Officer and a member of the Board of Directors of NitroMed, Inc., a pharmaceutical company, from September 1997 to March 2006 and as its President from September 2003 to March 2006. From 1979 to 1997, Dr. Loberg held a number of senior management positions at Bristol-Myers Squibb, including President of Bristol-Myers Squibb’s Oncology and Immunology, U.S. Primary Care, Northern Europe, Specialty Pharmaceuticals and Squibb Diagnostics. Dr. Loberg is a Director of IGM Biosciences, a developer of immunotherapeutics. He holds a B.S. in Chemistry from Trinity College and a Ph.D. in Chemistry from Washington University.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 91,188
Fiscal Year Total, USD 91,188

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Patrick Zenner

110,485

Peter Lawrence

1,168,540

Paolo Pucci

1,744,530

Marc Schegerin

--

Brian Schwartz

1,057,610

Timothy Barabe

92,438
As Of  31 Dec 2018